Insider: Rawcliffe Adrian Chief Executive Officer - Adaptimmune Therapeutics PLC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 44,327 | 0 | 44,327 |
| Value | $6,613.59 | $0.00 | $6,613.59 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/17/2025 | DDS | 30,601 | Direct | COM | $0.58 | $17,773.06 | 44,327 |
| 01/15/2025 | DDS | 29,096 | Direct | COM | $0.57 | $16,724.38 | 41,582 |
| 01/13/2025 | DDS | 12,539 | Direct | COM | $0.59 | $7,371.68 | 17,801 |
| 01/13/2025 | DDS | 17,934 | Direct | COM | $0.59 | $10,543.40 | 25,711 |
| 01/17/2024 | DDS | 30,080 | Direct | COM | $0.67 | $20,243.84 | 44,848 |
| 01/16/2024 | DDS | 9,304 | Direct | COM | $0.79 | $7,350.16 | 14,104 |
| 01/12/2024 | DDS | 17,257 | Direct | COM | $0.85 | $14,739.20 | 26,388 |
| 01/11/2024 | DDS | 11,945 | Direct | COM | $0.84 | $9,994.38 | 18,395 |
| 09/01/2023 | DDS | 2,403 | Direct | COM | $0.78 | $1,874.34 | 3,449 |
| 06/27/2023 | DDS | 2,333 | Direct | COM | $0.92 | $2,146.36 | 3,519 |
| 01/17/2023 | DDS | 10,057 | Direct | COM | $1.86 | $18,685.91 | 13,351 |
| 01/12/2023 | DDS | 18,763 | Direct | COM | $1.71 | $32,009.68 | 24,882 |
| 01/11/2023 | DDS | 13,042 | Direct | COM | $1.75 | $22,781.77 | 17,298 |
| 01/04/2023 | DDS | 5,073 | Direct | COM | $1.69 | $8,593.66 | 6,631 |
| 09/01/2022 | DDS | 2,536 | Direct | COM | $1.97 | $4,993.13 | 3,316 |
| 06/27/2022 | DDS | 2,562 | Direct | COM | $1.63 | $4,176.06 | 3,290 |
| 01/18/2022 | DDS | 11,096 | Direct | COM | $3.19 | $35,416.21 | 12,312 |
| 01/12/2022 | DDS | 3,046 | Direct | COM | $3.54 | $10,795.33 | 3,356 |
| 01/11/2022 | DDS | 14,362 | Direct | COM | $3.56 | $51,081.33 | 15,978 |
| 01/04/2022 | DDS | 5,532 | Direct | COM | $4.06 | $22,483.15 | 6,172 |
| 06/28/2021 | DDS | 2,794 | Direct | COM | $4.37 | $12,209.78 | 3,058 |
| 01/19/2021 | DDS | 9,879 | Direct | COM | $5.67 | $56,008.99 | 13,529 |
| 01/12/2021 | DDS | 2,707 | Direct | COM | $6.15 | $16,654.01 | 3,695 |
| 01/04/2021 | DDS | 4,967 | Direct | COM | $5.33 | $26,463.68 | 6,737 |
| 09/01/2020 | DDS | 2,776 | Direct | COM | $8.51 | $23,637.36 | 3,076 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research